I looked at the AGM presentation and on slide 7 it says:"Patient...

I looked at the AGM presentation and on slide 7 it says:

"Patient update: the patient has now completed 2
treatment cycles of Coramsine® therapy and is tolerating
the treatment well"

I think one can take that as positive in two ways. Firstly that there are no unacceptable side effects, and secondly, that it was worth doing a second treatment cycle.

However, I don't know anything about this area, so I have no idea what would prevent a patient undergoing a second treatment cycle. I presume some very bad reaction to the first cycle. I would like to know whether they would stop/not do the second cycle of the treatment if the first had no effect. I presume they would not stop unless, again, there was some adverse effect. I guess that if a treatment was extremely expensive and was having no effect, it would not go to a second cycle.

Does anyone know anything about this area and thus about the implications of the patient going onto a second cycle. Also how many cycles will they do?

Barley